陶氏病
小胶质细胞
细胞生物学
神经炎症
神经科学
认知功能衰退
生物
炎症
免疫学
医学
病理
神经退行性变
痴呆
疾病
作者
Victor Bodart‐Santos,Arun Reddy Ravula,Yang You,Mohammad Abdullah,Zhi Ruan,J. W Ellison,Stephanie Radhakishun,Nibedita Basu Ray,Bridgette C. Melvin,Aishe Kurti,Zhewei Liang,Yuta Sakai,Daniel R. O’Brien,Son N. Nguyen,Scott A. Shaffer,Lindsey Fiddes,Oleg Butovsky,Wolfdieter Springer,Seiko Ikezu,Seiko Ikezu
出处
期刊:Neuron
[Cell Press]
日期:2026-11-01
被引量:5
标识
DOI:10.1016/j.neuron.2026.10.007
摘要
P2X purinoreceptor 7 (P2RX7), an ATP-gated ion channel, contributes to Alzheimer's disease (AD) progression, but its molecular mechanisms remain unclear. Here, we show that genetic disruption of P2rx7 mitigates brain atrophy, tau accumulation, and cognitive impairment in PS19 mice. Microglia-specific, but not astrocyte-specific, deletion of P2rx7 suppresses tau propagation. Single-cell RNA sequencing identifies a previously unrecognized first-responding microglial state (FRM) with prominent P2rx7 expression. P2RX7 promotes the transition from FRM to an inflammatory microglial state enriched in extracellular vesicle (EV) biogenesis. P2RX7 increases EV loading of tau and of mitochondrial proteins and DNA, which activate cytosolic DNA sensing and interferon signaling in recipient microglia. Tau-containing microglial EVs disrupt neuronal endolysosomal integrity and facilitate endosomal tau escape and phosphorylation. Thus, P2RX7 regulates the FRM branch point, driving inflammatory microglial transition and EV-mediated spread of tau and toxic mitochondrial molecules and highlighting the P2RX7-EV axis as a therapeutic target in AD.
科研通智能强力驱动
Strongly Powered by AbleSci AI